NIH-funded research R21 grant

Understanding how specific gene mutations affect development in children

Official title: Dissecting out differential molecular phenotypes across Lysine(K) AcetylTransferase mutations in mouse development

Funded at University of California Los Angeles · NIH-10891666 · Data updated 2026-11-12

This study is looking at how changes in specific genes might affect the growth and development of children with certain syndromic disorders, like autism, by using mice to learn more about how these changes can disrupt normal development.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startAugust 1, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$191,244
NIH project number5R21OD035421-02
Project IDNIH-10891666 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0-11 years who have been diagnosed with syndromic disorders, particularly those associated with mutations in histone acetyltransferases.

Less likely to help

Patients who do not have genetic mutations related to histone acetyltransferases or who are outside the age range of 0-11 years may not benefit from this research.

What this research studies

This research investigates how mutations in certain genes, known as histone acetyltransferases, impact the development of children with syndromic disorders. By using mouse models, the study aims to uncover the mechanisms by which these mutations disrupt normal developmental processes, particularly in relation to conditions like autism and other developmental delays. The researchers will analyze the accessibility of DNA regions to understand how these genetic changes affect cell function and development. This work could provide insights into the underlying causes of various pediatric disorders.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and potential treatments for developmental disorders in children.

How similar studies have gone: Previous research has shown promising results in understanding the role of epigenetic factors in developmental disorders, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Arboleda, Valerie a — University of California Los Angeles
  • Study coordinator: Arboleda, Valerie a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.